Furthermore, high plasma YKL-40 levels are also associated with poor prognosis in non-cancerous diseases including cardiovascular, respiratory, digestive, endocrine, nervous, urinary and skeletal diseases [21]. Here, CHI3L1 is linked to bone disorder.